These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 32094485)

  • 1. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
    Sastre-Garriga J; Pareto D; Battaglini M; Rocca MA; Ciccarelli O; Enzinger C; Wuerfel J; Sormani MP; Barkhof F; Yousry TA; De Stefano N; Tintoré M; Filippi M; Gasperini C; Kappos L; Río J; Frederiksen J; Palace J; Vrenken H; Montalban X; Rovira À;
    Nat Rev Neurol; 2020 Mar; 16(3):171-182. PubMed ID: 32094485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structured Reporting in Multiple Sclerosis - Consensus-Based Reporting Templates for Magnetic Resonance Imaging of the Brain and Spinal Cord.
    Riederer I; Mühlau M; Wiestler B; Bender B; Hempel JM; Kowarik M; Huber T; Zimmer C; Andrisan T; Patzig M; Zimmermann H; Havla J; Berlis A; Behrens L; Beer M; Dietrich J; Sollmann N; Kirschke JS
    Rofo; 2023 Feb; 195(2):135-138. PubMed ID: 35913055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
    Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Casserly C; Seyman EE; Alcaide-Leon P; Guenette M; Lyons C; Sankar S; Svendrovski A; Baral S; Oh J
    J Neuroimaging; 2018 Nov; 28(6):556-586. PubMed ID: 30102003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.
    Liu Y; Duan Y; Huang J; Ren Z; Liu Z; Dong H; Weiler F; Hahn HK; Shi FD; Butzkueven H; Barkhof F; Li K
    Eur Radiol; 2018 Jan; 28(1):96-103. PubMed ID: 28667482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosis.
    Alroughani R; Deleu D; El Salem K; Al-Hashel J; Alexander KJ; Abdelrazek MA; Aljishi A; Alkhaboori J; Al Azri F; Al Zadjali N; Hbahbih M; Sokrab TE; Said M; Rovira À
    BMC Neurol; 2016 Nov; 16(1):240. PubMed ID: 27881095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy.
    Bagnato F; Gauthier SA; Laule C; Moore GRW; Bove R; Cai Z; Cohen-Adad J; Harrison DM; Klawiter EC; Morrow SA; Öz G; Rooney WD; Smith SA; Calabresi PA; Henry RG; Oh J; Ontaneda D; Pelletier D; Reich DS; Shinohara RT; Sicotte NL;
    J Neuroimaging; 2020 May; 30(3):251-266. PubMed ID: 32418324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What role should spinal cord MRI take in the future of multiple sclerosis surveillance?
    Rocca MA; Preziosa P; Filippi M
    Expert Rev Neurother; 2020 Aug; 20(8):783-797. PubMed ID: 32133874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
    JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal-cord MRI in multiple sclerosis.
    Lycklama G; Thompson A; Filippi M; Miller D; Polman C; Fazekas F; Barkhof F
    Lancet Neurol; 2003 Sep; 2(9):555-62. PubMed ID: 12941578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.
    Moccia M; Prados F; Filippi M; Rocca MA; Valsasina P; Brownlee WJ; Zecca C; Gallo A; Rovira A; Gass A; Palace J; Lukas C; Vrenken H; Ourselin S; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Barkhof F;
    Ann Neurol; 2019 Nov; 86(5):704-713. PubMed ID: 31385358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.
    Wattjes MP; Rovira À; Miller D; Yousry TA; Sormani MP; de Stefano MP; Tintoré M; Auger C; Tur C; Filippi M; Rocca MA; Fazekas F; Kappos L; Polman C; Frederik Barkhof ; Xavier Montalban ;
    Nat Rev Neurol; 2015 Oct; 11(10):597-606. PubMed ID: 26369511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis.
    Healy BC; Buckle GJ; Ali EN; Egorova S; Khalid F; Tauhid S; Glanz BI; Chitnis T; Guttmann CRG; Weiner HL; Bakshi R
    J Neuroimaging; 2017 Sep; 27(5):481-485. PubMed ID: 28261936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
    Sastre-Garriga J; Pareto D; Rovira À
    Neuroimaging Clin N Am; 2017 May; 27(2):289-300. PubMed ID: 28391787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging as an Outcome Measure in Multiple Sclerosis.
    Ontaneda D; Fox RJ
    Neurotherapeutics; 2017 Jan; 14(1):24-34. PubMed ID: 27699722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.
    Andelova M; Vodehnalova K; Krasensky J; Hardubejova E; Hrnciarova T; Srpova B; Uher T; Menkyova I; Stastna D; Friedova L; Motyl J; Lizrova Preiningerova J; Kubala Havrdova E; Maréchal B; Fartaria MJ; Kober T; Horakova D; Vaneckova M
    BMC Neurol; 2022 Jul; 22(1):270. PubMed ID: 35854235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.